Aim

Welcome to the Drug Delivery Lab!
Administration of free drug to treat diseases, in many cases, is associated with critical drawbacks like off-target effects and low in vivo stability. This hinders the treatment of the disease. With our versatile expertise, we aim to reduce these shortcomings. Our lab focuses on using wide range of tools and concepts such as nano- and micro-particles, hydrogels, scaffolds and 3D organoids to generate treatment for diseases like Tuberculosis and Osteoarthritis. With our translational outlook, we plan to create clinically viable therapeutic options to treat such diseases.

Latest News

    • 29th July 2022
      Vaishnavi joins the laboratory. Welcome!
    • 30th June 2022
      Edna's and Avijit's manuscript on OMV coated gold particles for TB vaccine has been accepted at Biomaterials Advances. Congratulations!
    • 21st June 2022
      Puvada and Akshi joins the laboratory. Welcome!

Latest Publications

  • George E.; Goswami A.; Lodhiya, T.; Padwal P.; Iyer S.; Gauttam I.; Sethi L.; Jeyasankar S.; Sharma P.S.; Mukherjee R.; Agarwal R., Immunomodulatory effect of mycobacterial outer membrane vesicles coated nanoparticles. Biomaterials Advances. 139 (2022) 213003. BioRxiv. Also check out a short video summary of the paper by the authors. Video link.
  • Narayan R.; Biji A.; Yadav R.; Sharma M.; Khatun O.; Rajmani R.; Sharma P.R.; Jeyasankar S.; Rani P.; Rao C.D.; Satchidanandanam V.; Das S.; Agarwal R.; Tripathi S., A broad-spectrum inhibitor of enveloped virus entry, effective against SARS-CoV-2 and IAV in vivo. BioRxiv.